GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (TSXV:TELO) » Definitions » Institutional Ownership

Telo Genomics (TSXV:TELO) Institutional Ownership : 0.14% (As of May. 21, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Telo Genomics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Telo Genomics's institutional ownership is 0.14%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Telo Genomics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Telo Genomics's Float Percentage Of Total Shares Outstanding is 0.00%.


Telo Genomics Institutional Ownership Historical Data

The historical data trend for Telo Genomics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Institutional Ownership Chart

Telo Genomics Historical Data

The historical data trend for Telo Genomics can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14

Telo Genomics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Telo Genomics (TSXV:TELO) Business Description

Traded in Other Exchanges
Address
101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

Telo Genomics (TSXV:TELO) Headlines